claim
Drugs targeting senescence-associated secretory phenotype (SASP), such as glucocorticoids, resveratrol, and protease inhibitors, attenuate chronic kidney disease (CKD) primarily by inhibiting NF-κB signals and reducing reactive oxygen species (ROS).
Authors
Sources
- Cellular rejuvenation: molecular mechanisms and potential ... - Nature www.nature.com via serper
Referenced by nodes (3)
- NF-κB concept
- chronic kidney disease concept
- senescence-associated secretory phenotype concept